PAR 6.12% 26.0¢ paradigm biopharmaceuticals limited..

Ann: Investor Presentation - $66m Capital Raise, page-2

  1. 9,801 Posts.
    lightbulb Created with Sketch. 1243
    10% market share of OA in US market in 2030 = $16.75B to $40.2B pa

    "Potential for it to become front line treatment"..........read up on why as existing health care models in our key target markets to "educate, increase activity and diet" aren't working for most. The personal and economic consequences on any given population are known and quite staggering.

    IPPS will fist and foremost help reset "pain" and and also function. If you're local GP (primary carer) then being able to suggest it may assist in also slowing the progression of OA (not necessarily reverse) it will give significant hope which in itself will make a world of difference.







 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.